DNA-HSP65

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDNA-HSP65
Drug Alias NameDNA-hsp65 cancer immunotherapy
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFarmacore
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFarmacore
Active IndicationsN/A
Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A